Cargando…
Reduction of Tat-interacting Protein 30 Expression Could be a Prognostic Marker in Bladder Urothelial Cancer
BACKGROUND: Tat-interacting protein 30 (TIP30) has been reported to be a tumor suppressor, with reduced or absent expression in various tumors. However, its role in bladder urothelial cancer (BUC) has not been investigated. Therefore, herein, we investigated the expression of TIP30 protein in BUC an...
Autores principales: | Li, Ye-Ping, Zhu, Jian-Fang, Huang, Ka-Te, Wang, Rong-Rong, Cai, Bing, Xie, Hui, Chen, Hong-De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776849/ https://www.ncbi.nlm.nih.gov/pubmed/29336367 http://dx.doi.org/10.4103/0366-6999.222325 |
Ejemplares similares
-
Reproducibility and Prognostic Value of WHO1973 and WHO2004 Grading Systems in TaT1 Urothelial Carcinoma of the Urinary Bladder
por: Mangrud, Ok Målfrid, et al.
Publicado: (2014) -
A low serum Tat-interacting protein 30 level is a diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Fan, Sha-Sha, et al.
Publicado: (2017) -
(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder
por: Larrinaga, Gorka, et al.
Publicado: (2021) -
Independent prognostic miRNAs for bladder urothelial carcinoma
por: Hu, Yingbo, et al.
Publicado: (2017) -
Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)